Skip to content

Clinical trials

Diabetic Retinopathy trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Phase: Not applicable Country / region: China Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20131
20151
20161
20194
20212
20221
20234
20241
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status5
Recruiting3
Not yet recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University6
Zhongshan Ophthalmic Center, Sun Yat-sen University3
Chengdu University of Traditional Chinese Medicine1
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong1
Peking Union Medical College Hospital1
Ruijin Hospital1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Shanghai Jiao Tong University School of Medicine1
Sichuan Provincial People's Hospital1
The First Affiliated Hospital of Anhui Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy22
Glaucoma4
Diabetes Mellitus3
Diabetes Mellitus, Type 22
Macular Degeneration2
Retinal Vein Occlusion2
Cataract1
Choroidal Neovascularization1
Conjunctivitis1
Diabetic Nephropathies1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.